Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

OKAVA Pharmaceuticals, a San Francisco-based biopharmaceutical company, has started a first-of-its-kind clinical trial evaluating a weight loss therapy for obese cats using a GLP-1 implant, the ...

A new study published in the journal Cell Metabolism strongly suggests that low doses of weight loss drugs like Ozempic and Zepbound can counteract aging in middle-aged mice, adding to the growing ...

As of Oct. 17, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...

The drug semaglutide—licensed for diabetes under Ozempic and weight loss under Wegovy—could help to reduce cocaine addiction. Scientists from the University of Gothenburg in Sweden and the University ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

Scientists have gene-hacked mice to produce their own Ozempic-like drugs — possibly, and provocatively, perhaps paving a path for humans to do so themselves one day. In a new study published in the ...